Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease

Respiration

Volumn 87, Issue 4, 2014, Pages 301-310

  Martinez Lozano Sinues, Pablo ^a   Meier, Lukas ^a   Berchtold, Christian ^a   Ivanov, Mark ^d   Sievi, Noriane ^b   Camen, Giovanni ^b   Kohler, Malcolm ^b,c   Zenobi, Renato ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Breath test; Chronic obstructive pulmonary disease; Exhaled biomarkers

Indexed keywords

ACETONE; BIOLOGICAL MARKER; INDOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXPIRED AIR; FEMALE; GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE; HUMAN; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICAL ANALYSIS; AGED; CLASSIFICATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; CASE CONTROL STUDY; CLINICAL TRIAL; METABOLISM; PROCEDURES; YOUNG ADULT;

ADULT; AGED; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

EID: 84898596933     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000357785     Document Type: Article

References (62)

1. Saetta M, Turato G, Maestrelli P, Mapp C, Fabbri L: Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304-1309.
2. Cazzola M, Novelli G: Biomarkers in COPD. Pulm Pharmacol Ther 2010; 23: 493-500.
3. OReilly P, Bailey W: Clinical use of exhaled biomarkers in COPD. Int J Chron Obstr Pulm Dis 2007; 2: 403-408.
4. Kharitonov SA, Barnes PJ: Exhaled biomarkers. Chest 2006; 130: 1541-1546.
5. Montuschi P: Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005; 356: 22-34.
6. Biernacki WA, Kharitonov SA, Barnes PJ: Increased leukotriene b4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58: 294-298.
7. de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, Motta A, Sofia M: Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 2008; 32: 1175-1183.
8. Montuschi P, Paris D, Melck D, Lucidi V, Ciabattoni G, Raia V, Calabrese C, Bush A, Barnes PJ, Motta A: NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 2012; 67: 222-228.
9. Motta A, Paris D, Melck D, de Laurentiis G, Maniscalco M, Sofia M, Montuschi P: Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J 2012; 39: 498-500.
10. Lucidi V, Ciabattoni G, Bella S, Barnes PJ, Montuschi P: Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis. Free Radic Biol Med 2008; 45: 913-919.
11. Montuschi P, Barnes PJ, Ciabattoni G: Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol Biol 2010; 594: 73-84.
12. Malerba M, Montuschi P: Non-invasive biomarkers of lung inflammation in smoking subjects. Curr Med Chem 2012; 19: 187-196.
13. Almstrand AC, Josefson M, Bredberg A, Lausmaa J, Sjovall P, Larsson P, Olin AC: TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls. Eur Respir J 2012; 39: 59-66.
14. Basanta M, Jarvis RM, Xu Y, Blackburn G, Tal-Singer R, Woodcock A, Singh D, Goodacre R, Paul Thomas CL, Fowler SJ: Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 2010; 135: 315-320.
15. Fens N, De Nijs SB, Peters S, Dekker T, Knobel HH, Vink TJ, Willard NP, Zwinderman AH, Krouwelse FH, Janssen HG, Lutter R, Sterk PJ: Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J 2011; 38: 1301-1309.
16. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ: Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180: 1076-1082.
17. Westhoff M, Litterst P, Maddula S, Bodeker B, Rahmann S, Davies A, Baumbach J: Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 2010; 13: 131-139.
18. Van Berkel JJBN, Dallinga JW, Moller GM, Godschalk RWL, Moonen EJ, Wouters EFM, Van Schooten FJ: A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 2010; 104: 557-563.
19. Montuschi P, Mores N, Trove A, Mondino C, Barnes PJ: The electronic nose in respiratory medicine. Respiration 2013; 85: 72-84.
20. Bofan M, Mores N, Baron M, Dabrowska M, Valente S, Schmid M, Trove A, Conforto S, Zini G, Cattani P, Fuso L, Mautone A, Mondino C, Pagliari G, DAlessio T, Montuschi P: Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. J Breath Res 2013; 7: 017103.
21. Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T: Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 2012; 39: 669-676.
22. Martinez-Lozano P, de la Mora JF: Electrospray ionization of volatiles in breath. Int J Mass Spectrom 2007; 265: 68-72.
23. Marti nez-Lozano P, Ferna ndez de la Mora J: Direct analysis of fatty acid vapors in breath by electrospray ionization and atmospheric pressure ionization-mass spectrometry. Anal Chem 2008; 80: 8210-8215.
24. Martinez-Lozano P, Zingaro L, Finiguerra A, Cristoni S: Secondary electrospray ionization-mass spectrometry: breath study on a control group. J Breath Res 2011; 5: 016002.
25. Martinez-Lozano Sinues P, Kohler M, Zenobi R: Monitoring diurnal changes in exhaled human breath. Anal Chem 2013; 85: 369-373.
26. Martinez-Lozano P, Fernandez de la Mora J: Direct analysis of fatty acid vapors in breath by electrospray ionization and atmospheric pressure ionization-mass spectrometry. Analytical Chemistry 2008; 80: 8210-8215.
27. Martinez-Lozano P, Fernandez de la Mora J: Electrospray ionization of volatiles in breath. Int J Mass Spectrom 2007; 265: 68-72.
28. Berchtold C, Meier L, Steinhoff R, Zenobi R: A new strategy based on real-Time secondary electrospray ionization and high-resolution mass spectrometry to discriminate endogenous and exogenous compounds in exhaled breath. Metabolomics 2013, DOI: 10. 1007/s11306-013-0568-z.
29. Wu C, Siems WF, Hill HH: Secondary electrospray ionization ion mobility spectrometry/mass spectrometry of illicit drugs. Anal Chem 2000; 72: 396-403.
30. Zhu J, Bean HD, Jimenez-Diaz J, Hill JE: Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple bacterial lung pathogens, a mouse model study. J Appl Physiol 2013; 114: 1544-1549.
31. Jiangjiang Z, Heather DB, Matthew JW, Laurie WL, Jane EH: Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints. J Breath Res 2013; 7: 016003.
32. Jiangjiang Z, Jaime J-D, Heather DB, Nirav AD, Minara IA, Lennart KAL, Jane EH: Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESIMS) breathprinting: from initial infection to clearance. J Breath Res 2013; 7: 037106.
33. Zhu J, Bean HD, Wargo M, Leclair L, Hill JE: Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints. J Breath Res 2013; 7: 016003.
34. Bean HD, Zhu J, Hill JE: Characterizing bacterial volatiles using secondary electrospray ionization mass spectrometry (SESI-MS). J Vis Exp 2011:e2664.
35. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI: Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009; 64: 744-748.
36. National Institutes of Health: Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO Workshop Report 2001 (pub No. 2701).
37. Martinez-Lozano Sinues P, Criado E, Vidal G: Mechanistic study on the ionization of trace gases by an electrospray plume. Int J Mass Spectrom 2012; 313: 21-29.
38. Vidakovic B: Statistics for Bioengineering Sciences: With MATLAB and WinBUGS Support. New York, Springer, 2011.
39. van den Berg R, Hoefsloot H, Westerhuis J, Smilde A, van der Werf M: Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genom 2006; 7: 142.
40. Jackson JE: A Users Guide to Principal Components. Hoboken, Wiley, 2005.
41. Martinez-Lozano Sinues P, Kohler M, Zenobi R: Human breath analysis may support the existence of individual metabolic phenotypes. PLoS ONE 2013; 8:e59909.
42. Barnes PJ: Future perspectives on exhaled biomarkers. Eur Respir Soc J 2010; 49: 237-246.
43. McKenzie JH, McDevitt JJ, Fabian MP, Hwang GM, Milton DK: Collection of aerosolized human cytokines using Teflon filters. PLoS ONE 2012; 7:e35814.
44. Phillips CO, Syed Y, Parthalain NM, Zwiggelaar R, Claypole TC, Lewis KE: Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls. J Breath Res 2012; 6: 036003.
45. Lindinger W, Hansel A, Jordan A: On-line monitoring of volatile organic compounds at PPTV levels by means of proton-Transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research. Int J Mass Spectrom Ion Processes 1998; 173: 191-241.
46. Smith D, San?l P: Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrom Rev 2005; 24: 661-700.
47. Spanel P, Dryahina K, Rejskova A, Chippendale TWE, Smith D: Breath acetone concentration; biological variability and the influence of diet. Physiol Meas 2011; 32:N23-N31.
48. Schwarz K, Pizzini A, Arendacka B, Zerlauth K, Filipiak W, Schmid A, Dzien A, Neuner S, Lechleitner M, Scholl-Burgi S, Miekisch W, Schubert J, Unterkofler K, Witkovsky V, Gastl G, Amann A: Breath acetone -aspects of normal physiology related to age and gender as determined in a PTR-MS study. J Breath Res 2009; 3: 027003.
49. Martinez-Lozano P, Rus J, Fernandez de la Mora G, Hernandez M, Fernandez de la Mora J: Secondary electrospray ionization (SESI) of ambient vapors for explosive detection at concentrations below parts per trillion. J Am Soc Mass Spectrom 2009; 20: 287-294.
50. Chen H, Wortmann A, Zhang W, Zenobi R: Rapid in vivo fingerprinting of nonvolatile compounds in breath by extractive electrospray ionization quadrupole time-of-flight mass spectrometry. Angew Chem Int Ed Engl 2007; 46: 580-583.
51. Fernandez de la Mora J: Ionization of vapor molecules by an electrospray cloud. Int J Mass Spectrom 2011; 300: 182-193.
52. Ross B: Sub-parts per billion detection of trace volatile chemicals in human breath using selected ion flow tube mass spectrometry. BMC Res Notes 2008; 1: 41.
53. Turner MA, Bandelow S, Edwards L, Patel P, Martin HJ, Wilson ID, Thomas CLP: The effect of a paced auditory serial addition test (PASAT) intervention on the profile of volatile organic compounds in human breath: a pilot study. J Breath Res 2013; 7: 017102.
54. Van den Velde S, Nevens F, Van hee P, van Steenberghe D, Quirynen M: GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B 2008; 875: 344-348.
55. Gambhir KK, McMenamy RH, Watson F: Positions in human serum albumin which involve the indole binding site. Sequence of 107-residue fragment. J Biol Chem 1975; 250: 6711-6719.
56. Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schafer H, Schutz B, Spraul M: Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci 2008; 105: 1420-1424.
57. Montuschi P: Toward a personalized pharmacotherapy of respiratory diseases. Front Pharmacol 2010; 1: 131.
58. Gamez G, Zhu L, Disko A, Chen H, Azov V, Chingin K, Kramer G, Zenobi R: Real-Time, in vivo monitoring and pharmacokinetics of valproic acid via a novel biomarker in exhaled breath. Chem Commun 2011; 47: 4884-4886.
59. Montuschi P: Pharmacological treatment of chronic obstructive pulmonary disease. Int J Chron Obstr Pulmon Dis 2006; 1: 409.
60. Martinez-Lozano Sinues P, Zenobi R, Kohler M: Analysis of the exhalome: a diagnostic tool of the future. Chest J 2013; 144: 746-749.
61. Fuso L, Mores N, Valente S, Malerba M, Montuschi P: Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Curr Med Chem 2013; 20: 1477-1495.
62. Montuschi P, Macagno F, Valente S, Fuso L: Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. Curr Med Chem 2013; 20: 1464-1476.